A joint ESTRO and AAPM guideline for development, clinical validation and reporting of artificial intelligence models in radiation therapy
dc.contributor.author | Hurkmans, C. | en |
dc.contributor.author | Bibault, J. E. | en |
dc.contributor.author | Brock, K. K. | en |
dc.contributor.author | van Elmpt, W. | en |
dc.contributor.author | Feng, M. | en |
dc.contributor.author | David Fuller, C. | en |
dc.contributor.author | Jereczek-Fossa, B. A. | en |
dc.contributor.author | Korreman, S. | en |
dc.contributor.author | Landry, G. | en |
dc.contributor.author | Madesta, F. | en |
dc.contributor.author | Mayo, C. | en |
dc.contributor.author | McWilliam, Alan | en |
dc.contributor.author | Moura, F. | en |
dc.contributor.author | Muren, L. P. | en |
dc.contributor.author | El Naqa, I. | en |
dc.contributor.author | Seuntjens, J. | en |
dc.contributor.author | Valentini, V. | en |
dc.contributor.author | Velec, M. | en |
dc.date.accessioned | 2024-07-31T09:57:09Z | |
dc.date.available | 2024-07-31T09:57:09Z | |
dc.date.issued | 2024 | en |
dc.identifier.citation | Hurkmans C, Bibault JE, Brock KK, van Elmpt W, Feng M, David Fuller C, et al. A joint ESTRO and AAPM guideline for development, clinical validation and reporting of artificial intelligence models in radiation therapy. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2024 Jun 3;197:110345. | en |
dc.identifier.pmid | 38838989 | en |
dc.identifier.doi | 10.1016/j.radonc.2024.110345 | en |
dc.identifier.uri | http://hdl.handle.net/10541/627088 | |
dc.description.abstract | BACKGROUND AND PURPOSE: Artificial Intelligence (AI) models in radiation therapy are being developed with increasing pace. Despite this, the radiation therapy community has not widely adopted these models in clinical practice. A cohesive guideline on how to develop, report and clinically validate AI algorithms might help bridge this gap. METHODS AND MATERIALS: A Delphi process with all co-authors was followed to determine which topics should be addressed in this comprehensive guideline. Separate sections of the guideline, including Statements, were written by subgroups of the authors and discussed with the whole group at several meetings. Statements were formulated and scored as highly recommended or recommended. RESULTS: The following topics were found most relevant: Decision making, image analysis, volume segmentation, treatment planning, patient specific quality assurance of treatment delivery, adaptive treatment, outcome prediction, training, validation and testing of AI model parameters, model availability for others to verify, model quality assurance/updates and upgrades, ethics. Key references were given together with an outlook on current hurdles and possibilities to overcome these. 19 Statements were formulated. CONCLUSION: A cohesive guideline has been written which addresses main topics regarding AI in radiation therapy. It will help to guide development, as well as transparent and consistent reporting and validation of new AI tools and facilitate adoption. | en |
dc.language.iso | en | en |
dc.title | A joint ESTRO and AAPM guideline for development, clinical validation and reporting of artificial intelligence models in radiation therapy | en |
dc.type | Article | en |
dc.contributor.department | Division of Cancer Sciences, The University of Manchester, Manchester, UK. | en |
dc.identifier.journal | Radiotherapy and Oncology | en |
dc.description.note | en] |